--- title: "Aris Mining Corporation Stock 12‑Month Price Target Cut to $30.58, Implies 91% Upside" type: "News" locale: "en" url: "https://longbridge.com/en/news/291969611.md" description: "Aris Mining Corporation's average 12-month price target was lowered from $31.03 to $30.58 by five analysts, with estimates ranging between $25.31 and $37. Despite the cut, the consensus rating remains 'Buy'. Based on the July 6 closing price, the new target implies approximately 91% potential upside." datetime: "2026-07-07T19:20:06.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/291969611.md) - [en](https://longbridge.com/en/news/291969611.md) - [zh-HK](https://longbridge.com/zh-HK/news/291969611.md) generator: "portal-rs" --- # Aris Mining Corporation Stock 12‑Month Price Target Cut to $30.58, Implies 91% Upside - According to estimates from 5 analysts, Aris Mining Corporation stock's average price target has fallen from $31.03 to $30.58, with forecasts ranging from $25.31 to $37 per share - Based on the Jul. 6 closing price, the updated target implies approximately 91% potential upside - Consensus rating remains at “Buy” across 5 covering analysts, with 5 Buys, 0 Holds and 0 Sells Explore more price target data and ratings for Aris Mining Corporation on the , and track all previous and future analyst recommendations for Aris Mining Corporation in the dedicated News Flow. **Disclaimer** Select reference data provided by FactSet. Copyright © 2026 FactSet Research Systems Inc. This information is not a recommendation for what you should do personally and does not constitute investment advice. ### Related Stocks - [ARIS.US](https://longbridge.com/en/quote/ARIS.US.md) - [FDS.US](https://longbridge.com/en/quote/FDS.US.md) - [ARMN.US](https://longbridge.com/en/quote/ARMN.US.md) ## Related News & Research - [Aris Mining (TSX:ARIS) Returned To Profit, Is The Upside Already Priced In?](https://longbridge.com/en/news/294448097.md) - [Does Interparfums’ (IPAR) Earnings Upgrade Hint At Deeper Strength In Its Profit Model?](https://longbridge.com/en/news/296564505.md) - [CONMED (CNMD) Could Be 8% Overvalued Following Its Recent Rebound](https://longbridge.com/en/news/296318744.md) - [Arcus Biosciences (RCUS) Stock Looks Strong On Returns But Stretched On Sales](https://longbridge.com/en/news/296529363.md) - [Google falsely said Sam Altman was dead — and suggested vandalized public sources could be to blame](https://longbridge.com/en/news/295717118.md) --- > **Disclaimer: This article is for reference only and does not constitute any investment advice.**